Abstract 4572: Characterization of the potent and selective A2aR antagonist AB928 for the treatment of cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Abstract 4572: Characterization of the potent and selective A2aR antagonist AB928 for the treatment of cancer

Published:2017-07-01 Issue: Volume: Page:
ISSN:
Container-title:Clinical Research (Excluding Clinical Trials)
language:
Short-container-title:

Author:

Walters Matt J.,Tan Joanne B.,Becker Annette,Yi Fangfang,Park Tim,Leleti Manmohan R.,Rosen Brandon,Sharif Ehesan,Debien Laurent,Young Steve,Lim Wan Hsin,Garrido-Shaqfeh Stefan,Jaen Juan C.,Powers Jay P.

Publisher

American Association for Cancer Research

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural insight into the dual-antagonistic mechanism of AB928 on adenosine A2 receptors;Science China Life Sciences;2024-01-31

2. Structural insights into dual-antagonize mechanism of AB928 on adenosine A₂receptors;2023-07-01

3. Adenosine A2A Receptor Antagonists: Chemistry, SARs, and Therapeutic Potential;Topics in Medicinal Chemistry;2023

4. Pd-Catalyzed Cyanation of a Bromoaryl Carboxylate En Route to Etrumadenant: Robust Process with Low Catalyst Loading Enabled by Preactivation;Organic Process Research & Development;2022-11-07

5. Impact of the selective A2AR and A2BR dual antagonist AB928/etrumadenant on CAR T cell function;British Journal of Cancer;2022-10-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP